SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Cardiovascular Drug Development · Study

ReviewCardiovascular Drug Development

Christopher B. Fordyce2015

OA

Reviewbronze2015

Cardiovascular Drug Development

Christopher B. Fordyce · Matthew T. Roe · Tariq Ahmad · Peter Libby · JEFFREY S. BORER · William R. Hiatt +15 more

202 citations·0/0 files stored·Journal of the American College of Cardiology

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Statistical Methods in Clinical Trials Pharmaceutical industry and healthcare

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 202 citations exist upstream.

References

2006Projections of Global Mortality and Burden of Disease from 2002 to 2030 2004Can the pharmaceutical industry reduce attrition rates?2002Rating Banks: Risk and Uncertainty in an Opaque Industry 2012A Tale of Coronary Artery Disease and Myocardial Infarction 2011The productivity crisis in pharmaceutical R&D 2010Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs 2010Deconstructing the Drug Development Process: The New Face of Innovation 2010Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2016Changing R&D models in research-based pharmaceutical companiesreview · 4 shared references 2014Scientific and Regulatory Reasons for Delay and Denial of FDA Approval of Initial Applications for New Drugs, 2000-2012article · 4 shared references 2013Clinical Approval Success Rates for Investigational Cancer Drugsarticle · 3 shared references 2017Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indicationsreview · 3 shared references 2013Models for open innovation in the pharmaceutical industryarticle · 3 shared references 2021Approval success rates of drug candidates based on target, action, modality, application, and their combinationsarticle · 3 shared references

Details

Year2015

Typereview

Published2015-04-01

VenueJournal of the American College of Cardiology

ISSN-L0735-1097

Languageen

Citations202

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1016/j.jacc.2015.03.016

openalex_workW216869754

Links

Imported from OpenAlex (CC0) — nothing here is generated.